These six companies together control 96% of the PBM market. HOW AND WHY ARE PBMs FACING INTENSE SCRUTINY? The FTC began investigating the top PBMs and their impact on pricing and access to ...

The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...

A recent report by federal regulators said PBMs drive up costs. U.S. Sen. Mike Crapo, R-Idaho, has pushed for federal PBM ...

The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...

The Federal Trade Commission said that it is suing the three major US pharmacy benefit managers over their role in the ...

Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) (as seller), a life science biotechnology company pioneering the use of nature-derived psilocybin ...

The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.

Market is Growing at CAGR of 6.0%, Increasing Demand for Cost-Effective Drug Management Solutions Propels Market Growth.Pune, ...

Now that Congress has wrapped up most of its health care legislative work before the elections, the contours of what could be included in an end-of-year package are taking shape.